NEWS
News Articles
Biden says U.S. will have enough vaccine for 300 million people by end of July
The administration used options in existing contracts to purchase another 200 million doses, increasing supply by 50 percent President Biden said Thursday that his administration had finalized deals for another 200 million doses of the two coronavirus vaccines authorized in the United States, giving the country enough vaccine by the end of July to cover every American…
Read MoreGeoVax Announces Pricing of $9.0 Million Bought Deal Offering
ATLANTA, GA, February 8, 2021 – GeoVax Labs, Inc. (Nasdaq: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced that it has entered into an underwriting agreement with Maxim Group LLC under which the underwriter has agreed to purchase, on a firm commitment basis, 1,440,000 shares…
Read MoreEli Lilly’s antibody combination receives FDA emergency use authorization for COVID-19
Feb 9 (Reuters) – Eli Lilly’s combination antibody therapy to fight COVID-19 has been granted emergency use authorization by the U.S. Food and Drug Administration, Lilly said on Tuesday. Lilly’s combination therapy of two antibodies, bamlanivimab and etesevimab, helped cut the risk of hospitalization and death in COVID-19 patients by 70%, data from a late-stage…
Read MoreBig Lessons From The Rapid Development Of COVID Vaccines
The first COVID-19 vaccines – products of Pfizer-BioNTech and Moderna have been administered in the United States. Research companies – including Johnson & Johnson, Novavax, and AstraZeneca – are also making incredible progress to bring a vaccine to the public. We have come this far and quickly because biopharmaceutical research companies are devoting unprecedented time…
Read MorePress Release: House Bill 304, Governor Kemp’s Georgia Made Medical Manufacturing Act
“As the leading life sciences organization in the state, Georgia Bio fully supports House Bill 304, Governor Kemp’s Georgia Made Medical Manufacturing Act. The COVID-19 pandemic has taught us many lessons, but chief among those is that we must be able to provide for the public health of our citizens. This legislation will highlight the…
Read MoreBristol Myers finally wins FDA approval for cancer cell therapy
Dive Brief: The Food and Drug Administration on Friday approved Breyanzi, a cancer cell therapy from Bristol Myers Squibb, for the treatment of late-stage lymphoma. Breyanzi, previously called liso-cel, is cleared for use in adults with certain types of large B-cell lymphoma whose cancer has progressed after at least two prior treatments. It’s the first cell…
Read More